期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
Cosmc和T-合酶在黏蛋白型O-聚糖合成中的重要作用及其与人类疾病的相关性 被引量:4
1
作者 巨同忠 Richard D.Cummings +1 位作者 靳嘉巍 查锡良 《生命科学》 CSCD 北大核心 2011年第7期630-642,共13页
从核心1结构(Galβ1,3GalNAcα1-O-Ser/Thr,core 1 structure,T antigen)中衍生出来的黏蛋白型O-聚糖在很多生理过程中发挥重要的生物学功能。T-合酶(core 1β3-galactosyltransferase,T-synthase)是合成核心1结构的唯一糖基转移酶,它... 从核心1结构(Galβ1,3GalNAcα1-O-Ser/Thr,core 1 structure,T antigen)中衍生出来的黏蛋白型O-聚糖在很多生理过程中发挥重要的生物学功能。T-合酶(core 1β3-galactosyltransferase,T-synthase)是合成核心1结构的唯一糖基转移酶,它主要的功能是将半乳糖(Galactose)添加到GalNAcα1-Ser/Thr(Tn抗原)糖链上。但是在人体和其他脊椎动物中有活性的T-合酶的形成需要一个重要的伴侣分子Cosmc;Cosmc功能丧失将直接导致T-合酶失活,其结果是机体细胞只能合成Tn抗原以及唾液酰化Tn(sialylTn,STn,Neu5Acα2,6GalNAcα1-O-Ser/Thr)。综述目前对T-合酶和Cosmc的研究以及在人类疾病(如异常O-聚糖表达相关的Tn综合征、IgA肾病和肿瘤)发生发展中的作用。 展开更多
关键词 O-聚糖 t-合酶 分子伴侣 Cosmc Tn抗原
原文传递
过敏性紫癜患者B淋巴细胞Cosmc、T-合酶mRNA的表达与血清低半乳糖基化IgA1水平检测 被引量:5
2
作者 师绍敏 杨云 +9 位作者 罗丁 霍建丽 王大虎 马耀辉 马海霞 任翠敏 郭兵申 李昕 王兴楠 刘强 《中华皮肤科杂志》 CAS CSCD 北大核心 2020年第4期285-289,共5页
目的探讨外周血B淋巴细胞Cosmc、T-合酶及血清低半乳糖基化IgA1(Gd-IgA1)在过敏性紫癜(HSP)患者中的变化。方法2014年1-8月在河北医科大学第二医院皮肤性病科收集门诊或住院HSP患者56例,分为4组,即皮肤型组(22例)、关节型组(9例)、腹型... 目的探讨外周血B淋巴细胞Cosmc、T-合酶及血清低半乳糖基化IgA1(Gd-IgA1)在过敏性紫癜(HSP)患者中的变化。方法2014年1-8月在河北医科大学第二医院皮肤性病科收集门诊或住院HSP患者56例,分为4组,即皮肤型组(22例)、关节型组(9例)、腹型组(12例)、肾型组(13例)。20例健康志愿者为健康对照组。采用实时荧光定量PCR检测患者外周血B淋巴细胞Cosmc、T-合酶mRNA表达量,凝集素亲和ELISA法检测血清Gd-IgA1水平。多组间比较采用单因素方差分析或Kruskal-Wallis H检验,两两多重比较采用LSD-t检验或Nemenyi检验,相关性分析采用Spearman秩相关检验。结果皮肤型组发病时长为(6.27±3.09)d,关节型组(5.56±3.05)d,腹型组(6.75±3.75)d,肾型组(26.23±14.12)d,差异有统计学意义(χ2=26.19,P<0.05);肾型组发病时长明显长于其他3组病例组(均P<0.05)。皮肤型、关节型、腹型、肾型组和健康对照组Cosmc mRNA相对表达量分别为0.849±0.239、0.767±0.181、0.719±0.183、0.459±0.121、1.146±0.232,各组间差异有统计学意义(F=23.37,P<0.05),各病例组均低于健康对照组(P<0.01),且肾型组低于其他3组病例组(均P<0.01)。各病例组与健康对照组的外周血B淋巴细胞T-合酶mRNA表达水平差异无统计学意义(F=1.05,P>0.05)。皮肤型、关节型、腹型、肾型紫癜组及健康对照组间血清Gd-IgA1水平差异有统计学意义(F=7.06,P<0.05),各病例组Gd-IgA1水平均高于健康对照组(均P<0.05),肾型组高于其他3组病例组(均P<0.05)。HSP组患者血清Gd-IgA1水平与Cosmc mRNA相对表达量显著负相关,rs=-0.50,P<0.01。结论HSP患者Cosmc mRNA表达水平下降,血清Gd-IgA1水平升高,二者呈负相关。 展开更多
关键词 紫癜 过敏性 B淋巴细胞 免疫球蛋白A Cosmc t-合酶 低半乳糖基化IgA1
原文传递
Expression of nitric oxide synthase in T-cell-dependent liver injury initiated by ConA in Kunming mice 被引量:1
3
作者 张修礼 曲建慧 +5 位作者 万谟彬 权启镇 孙自勤 王要军 江学良 李文波 《Journal of Medical Colleges of PLA(China)》 CAS 2004年第2期112-114,共3页
Objective: To investigate whether nitric oxide synthase (NOS) is expressed in T-cell-dependent liver injury initiated by concanavalin A (ConA) in Kunming mice and study the possible effect of nitric oxide(NO) on liver... Objective: To investigate whether nitric oxide synthase (NOS) is expressed in T-cell-dependent liver injury initiated by concanavalin A (ConA) in Kunming mice and study the possible effect of nitric oxide(NO) on liver injury models. Methods: Liver injury in Kunming mice was induced by administration of ConA through tail vein. Expression of NOS in the liver was detected by NADPH diaphorase staining method. The possible effect of NO on liver injury models was obtained by L-NAME injection to suppress synthesis of NO. Results: NOS has a strong expression in hepatocytes after ConA injection, especially in those close to the central vein, while only a weak expression was found in the epithelial cells in control group. Liver injury became more serious when NO synthesis was inhibited by L-NAME, accompanied by great malondialdehyde(MDA) increase in serum and severe intrahepatic vascular thrombosis. Conclusion: NOS markedly expressed in ConA-induced liver injury, which may subsequently promote nitric oxide synthesis. Increasement of nitric oxide has a protective effect on ConA-induced liver injury. 展开更多
关键词 nitric oxide synthase nitric oxide concanavalin A liver injury
下载PDF
Foxp3 rs2294021 polymorphism contributes to the susceptibility to breast carcinoma
4
作者 Xu Han Guangming Bao Yifeng Zhou 《The Chinese-German Journal of Clinical Oncology》 CAS 2010年第5期253-257,共5页
Objective:Foxp3,the main regulator of Treg (regulatory T) cells, is down-regulated in breast carcinoma and other cancers. The rs2294021 Foxp3 polymorphism contributes to Foxp3 down-regulation, thereby weakens its tumo... Objective:Foxp3,the main regulator of Treg (regulatory T) cells, is down-regulated in breast carcinoma and other cancers. The rs2294021 Foxp3 polymorphism contributes to Foxp3 down-regulation, thereby weakens its tumor suppressing activity. The aim of our study was to evaluate the potential influence of Foxp3 polymorphism on breast cancer, we conducted a case-control study in Han Chinese women. Methods: Foxp3 genotyping was conducted in 677 breast carcinoma patients and 828 age-frequency matched cancer-free controls. Genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Experiment data was analyzed using Chi-square test and SPSS software. Results: The T/C genotype was found to be significantly associated with increased risk of breast carcinoma occurrence (OR = 1.462; 95% CI 1.165-1.833, P = 0.001) compared with the T/T or C/C (OR 1.143; 95% CI 0.838-1.559, P = 0.397) genotype. The increased risk for breast carcinoma related to heterozygous genotype was more pronounced in subjects over 50 years (OR 1.631; 95% CI 1.116-2.383, P = 0.011). No significant association was found between the polymorphism and the ER/PR status, metastasis or tumor stage of breast cancer. Conclusion: Our findings suggest that rs2294021 Foxp3 polymorphism may be a potential contributor for development of breast carcinoma in Han Chinese women. 展开更多
关键词 FOXP3 breast carcinoma single nucleotide polymorphism (SNP) regulatory T cells
下载PDF
Changes in tumor-antigen expression profile as human small-cell lung cancers progress
5
作者 Li-Sheng Ge Neil T. Hoa +4 位作者 Nils Lambrecht Maria Dacosta-Iyer Yi Ouyang Amir Abolhoda Martin R. Jadus 《Cancer Biology & Medicine》 SCIE CAS CSCD 2015年第2期96-105,共10页
Objective: Our group has previously observed that in patients with small-cell lung cancers (SCLCs), the expression of a tumor antigen, glioma big potassium (gBK) ion channel, is higher at the time of death than w... Objective: Our group has previously observed that in patients with small-cell lung cancers (SCLCs), the expression of a tumor antigen, glioma big potassium (gBK) ion channel, is higher at the time of death than when the cancer is first treated by surgical resection. This study aimed to determine whether this dichotomy was common in other potential lung tumor antigens by examining the same patient samples using our more extensive profile analysis of tumor-antigen precursor protein (TAPP). We then tested the hypothesis that therapeutic intervention may inadvertently cause this increased gBK production. Methods: SCLC samples (eight surgical resections and three autopsy samples) and three control lungs were examined by quantitative real-time polymerase chain reaction for 42 potential TAPPs that represent potential T-cell-mediated immunological targets. Results: Twenty-two TAPP mRNAs displayed the same profile as gBK, i.e., more mRNAs were expressed at autopsy than in their surgical counterparts. B-cyclin and mouse double minute 2, human homolog of PS3-binding protein were elevated in both autopsy and surgical specimens above the normal-lung controls. When HTB119 cells were incubated with doxorubicin, gBK was strongly induced, as confirmed by intracellular flow cytometry with a gBK-specific antibody. Conclusion: Our findings suggested that more immunological targets became available as the tumor responded to chemotherapy and proceeded toward its terminal stages. 展开更多
关键词 Small-cell lung cancer (SCLC) glioma big potassium (gBK) ion channel tumor antigens immunoprevention real-timepolymerase chain reaction t-LYMPHOCYTES
下载PDF
Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations 被引量:2
6
作者 XU Ling LU Yu Hong +9 位作者 LAI Jing YU Wei ZHANG Yi Kai JIN Zhen Yi XU Yan CHEN Jie ZHA Xian Feng CHEN Shao Hua YANG Li Jian LI Yang Qiu 《Science China(Life Sciences)》 SCIE CAS CSCD 2015年第12期1276-1281,共6页
Diversity in the T cell receptor(TCR) repertoire provides a miniature defense ability for the T cell immune system that may be related to tumor initiation and progression. Understanding the T cell immune status of leu... Diversity in the T cell receptor(TCR) repertoire provides a miniature defense ability for the T cell immune system that may be related to tumor initiation and progression. Understanding the T cell immune status of leukemia patients is critical for establishing specific immunotherapies. Previous studies have reported abnormal TCR repertoires and clonally expanded TCR V? T cells in chronic myeloid leukemia in chronic phase(CP-CML). In this study, we investigated the distribution and clonality of the TCR V? repertoire in 4 cases with imatinib-resistant CML in blast crisis(BC-CML) with abelson murine leukemia viral oncogene homolog 1(ABL1) kinase domain mutations(KDMs). Examination of TCR V? expression and clonality was performed by reverse transcription-polymerase chain reaction(RT-PCR) and Gene Scan analysis. Significantly skewed TCR V? repertoires were observed in BC-CML patients with different KDMs, and 4 to 8 oligoclonally expanded TCR V? subfamilies could be identified in each sample. Intriguingly, a relatively highly expanded V?9 clone with the same length as complementarity-determining region 3(CDR3)(139 bp) was found in all three CML patients in lymphoid blast crisis(LBC-CML) who had different KDMs, but the clone was not detected in the only CML patient in myeloid blast crisis(MBC-CML). In conclusion, restricted TCR V? repertoire expression and decreased clone complexity was a general phenomenon observed in the BC-CML patients with different KDMs, indicating the T-cell immunodeficiency of these patients. In addition, clonally expanded V?9 T cell clones may indicate a specific immune response to leukemia-associated antigens in LBC-CML patients. 展开更多
关键词 T cell repertoire chronic myeloid leukemia blast crisis imatinib resistance BCR-ABL mutation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部